The present invention relates to formulations of poorly bioavailable and/or poorly absorbable, and/or poorly water soluble therapeutic agents. The invention features an enterically coated tablet or capsule comprising a pharmaceutical composition comprising a biopolymer, a cephalosporin and a polyoxyethylene alkyl ether absorption enhancer. Methods of making and using the pharmaceutical compositions are also described.